ATC Group: D07AC21 Ulobetasol

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of D07AC21 in the ATC hierarchy

Level Code Title
1 D Dermatologicals
2 D07 Corticosteroids, dermatological preparations
3 D07A Corticosteroids, plain
4 D07AC Corticosteroids, potent (group III)
5 D07AC21 Ulobetasol

Active ingredients in D07AC21

Active Ingredient Description
Ulobetasol

Ulobetasol is a corticosteroid used for for the topical treatment of plaque psoriasis. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in plaque psoriasis is unknown.

Related product monographs

Title Information Source Document Type  
ULTRAVATE Lotion FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

Brazil (BR)

Canada (CA)

Ecuador (EC)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.